A. Mastrobattista

发表

Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art

M. Andreoni, D. Goletti, E. Girardi, 2021, Microorganisms.

IPF: treatment and prevention of pulmonary exacerbations

L. Richeldi, R. Inchingolo, Carola Condoluci, 2017 .

Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital

C. Agrati, S. Topino, G. Ippolito, 2021, International Journal of Infectious Diseases.

Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia

C. Agrati, S. Topino, G. Ippolito, 2020, Scientific Reports.

Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?

L. Richeldi, R. Inchingolo, A. Smargiassi, 2017, Expert opinion on pharmacotherapy.

Increased Association of Pulmonary Thromboembolism and Tuberculosis during COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital

S. Topino, S. Ianniello, D. Goletti, 2022, Antibiotics.

Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report

G. Ippolito, Alimuddin Zumla, F. Palmieri, 2020, International Journal of Infectious Diseases.

Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone

V. Poletti, L. Calandriello, A. Larici, 2018, The clinical respiratory journal.

Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital

G. D'offizi, E. Nicastri, A. Antinori, 2021, Journal of clinical medicine.